Use of riluzole

MNMED_RILUZOLE

No definition available.

Endpoint definition

FinnGen phenotype data

321302 individuals

diagram downward connector

Apply sex-specific rule None

321302

diagram downward connector

Check conditions None

321302

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC N07XX02

101

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

63

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

63

diagram downward connector

Include endpoints None

63

diagram downward connector
MNMED_RILUZOLE

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
?
Number of individuals
63 26 37
?
Unadjusted prevalence (%)
0.02 0.01 0.03
?
Mean age at first event (years)
65.22 66.94 64.01

?
Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: MNMED_RILUZOLE – Use of riluzole
GWS hits:

Survival analyses between endpoints

Plot

before Use of riluzole
after Use of riluzole

loading spinner Loading survival analyses plot